PHAXIAM Therapeutics S.A. (PHXM) Financials

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$0
Day's range
$0
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80MEarning20172017201820182019201920202020202120212022202220232023-950%-950%-1000%-1000%-1050%-1050%-1100%-1100%-1150%-1150%-1200%-1200%Profit Margin
Profit Margin
Revenue
Earnings

PHXM Income statement / Annual

Last year (2023), PHAXIAM Therapeutics S.A.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, PHAXIAM Therapeutics S.A.'s net income was -$23.49 M. See PHAXIAM Therapeutics S.A.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $0.00 $0.00 $0.00 $0.00 $5.28 M $0.00 $3.36 M $19.72 M $10.78 M $4.37 M
Cost of Revenue $1.61 M $2.91 M $5.38 M $4.99 M $4.22 M $797.00 K $530.00 K $19.72 M $10.78 M $4.37 M
Gross Profit -$1.61 M -$2.91 M -$5.38 M -$4.99 M $1.07 M -$33.47 M -$25.46 M $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0 0.2 0 -7.57 0 0 0
Research and Development Expenses $9.84 M $15.92 M $40.22 M $53.28 M $52.19 M $33.47 M $25.46 M $19.53 M $10.53 M $2.24 M
General & Administrative Expenses $0.00 $13.89 M $15.10 M $14.97 M $17.16 M $14.60 M $8.79 M $6.66 M $7.62 M $4.36 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $13.97 M $13.89 M $15.10 M $14.97 M $17.16 M $14.60 M $8.79 M $6.66 M $7.62 M $4.36 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$493.00 K
Operating Expenses $23.81 M $27.15 M $56.52 M $68.83 M $69.36 M $48.07 M $34.25 M $25.78 M $18.14 M $4.58 M
Cost And Expenses $25.42 M $32.08 M $60.70 M $68.83 M $69.36 M $48.07 M $34.25 M $22.39 M $15.58 M $8.95 M
Interest Income $259.00 K $4.45 M $13.00 K $889.00 K $2.95 M $163.00 K $539.00 K $545.00 K $0.00 $0.00
Interest Expense $196.00 K $1.36 M $2.14 M $5.35 M $1.53 M $9.00 K $3.18 M $4.00 K $5.00 K $6.80 K
Depreciation & Amortization $1.61 M $2.91 M $5.38 M $4.99 M -$2.95 M -$9.06 M $530.00 K $427.00 K $288.00 K $250.24 K
EBITDA -$23.81 M -$22.69 M -$47.46 M -$67.94 M $5.28 M -$47.27 M -$33.72 M -$25.78 M -$15.25 M -$10.72 M
EBITDA Ratio 0 0 0 0 1 0 -10.02 -1.31 -1.41 -2.45
Operating Income Ratio 0 0 0 0 1 0 -9.18 -1.33 -1.71 -2.05
Total Other Income/Expenses Net $683.00 K $32.38 M $2.72 M -$747.00 K -$67.94 M $5.40 M -$2.64 M $4.31 M -$1.65 M -$1.46 M
Income Before Tax -$24.73 M $293.00 K -$53.80 M -$73.30 M -$62.66 M -$38.22 M -$33.53 M -$21.90 M -$17.24 M -$10.40 M
Income Before Tax Ratio 0 0 0 0 -11.86 0 -9.97 -1.11 -1.6 -2.38
Income Tax Expense -$1.25 M $521.00 K $2.00 K $3.00 K -$1.00 K $2.00 K -$3.00 K $10.00 K -$2.22 M -$1.54 M
Net Income -$23.49 M -$227.00 K -$53.80 M -$73.30 M -$62.66 M -$38.22 M -$33.53 M -$21.91 M -$15.01 M -$8.86 M
Net Income Ratio 0 0 0 0 -11.86 0 -9.97 -1.11 -1.39 -2.03
EPS -4.62 -0.1 -22.7 -36.55 -3.49 -2.13 -1.87 -2.74 -2.16 -1.51
EPS Diluted -4.62 -0.1 -22.7 -36.55 -3.49 -2.13 -1.87 -2.74 -2.16 -1.51
Weighted Average Shares Out $5.08 M $3.10 M $2.37 M $2.01 M $1.94 M $1.94 M $1.23 M $7.98 M $6.96 M $5.88 M
Weighted Average Shares Out Diluted $5.08 M $3.10 M $2.37 M $2.01 M $1.94 M $1.94 M $1.23 M $7.98 M $6.96 M $5.88 M
Link